Figure 2From: Effects of aging and type 2 diabetes on resting and post occlusive hyperemia of the forearm; the impact of rosiglitazoneThis figure shows the blood flow in the forearm of the subjects with diabetes at rest (cc/ 100 ml tissue/minute) before taking rosiglitazone (pre) and at two weeks (2 w), four weeks (4 w), and three months (3 m) taking 4 ml per day of Rosiglitazone. All data is shown with the appropriate standard deviation.Back to article page